Envestnet Portfolio Solutions Inc. lifted its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 3.0% ...

Globus Medical (NYSE:GMED – Get Free Report) had its target price dropped by investment analysts at Truist Financial from $90.00 to $82.00 in a research note issued to investors on Tuesday,Benzinga ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Learn more about whether Globus Medical, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor ...

Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to share on LinkedIn (Opens in new window) Globus Medical, Inc. reported $657,293 million in sales and ...

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

A Tesla store in Colma, California, on Monday, March 10, 2025. Reporter Tesla sales have been faltering worldwide as consumers push back against the company’s CEO Elon Musk and his political ...

AUDUBON, Pa. - Globus Medical, Inc. (NYSE: GMED), a prominent musculoskeletal technology company with a market capitalization of $10.08 billion and impressive revenue growth of 60.62% in the last ...